Samuel Rabkin
0000-0003-2344-2795
Massachusetts General Hospital and Harvard Medical School
2 papers found
Refreshing results…
A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS)
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
Missing publications? Search for publications with a matching author name.